Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.375
Bid: 1.35
Ask: 1.40
Change: 0.05 (3.77%)
Spread: 0.05 (3.704%)
Open: 1.325
High: 1.375
Low: 1.275
Prev. Close: 1.325
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: CentralNic expects revenue growth ahead of views

Mon, 14th Feb 2022 22:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Wentworth Resources PLC - Tanzania-focused natural gas production company - Says competent persons report for 2021 reconfirms the long-term potential at Mnazi Bay gas license in Tanzania. Estimates its share of gross reserves to be around 135.2 billion cubic feet of gas, with an after-tax net present value of USD108.1 million.

----------

Equals Group PLC - London-based payments services for small and medium enterprises - Says that via its subsidiary Spectrum Payment Services Ltd, it has been accepted by the European Payments Council to join the SEPA Instant and SEPA Credit Transfer schemes for euro payments. Integration with SEPA, combined with Equals' direct membership of the UK's Faster Payments Scheme, means that all transactions in the key currency pair of GBP-EUR become instant for Equals customers, it says.

----------

Polarean Imaging PLC - medical‑imaging technology company - Company has received an additional research unit order for a Xenon Polariser system from McMaster University in Ontario, Canada. The newest unit, version 9820, will supplement the University's existing hyperpolarisation 129Xe MRI research programme which is currently using a prior Polarean model - version 9800.

----------

Open Orphan PLC - pharmaceutical services provider - Says subsidiary hVIVO recently launched the Seasonal Transmissible Respiratory Virus SurvEy project to collect respiratory viral strains suitable for challenge agents from consenting hVIVO employees. Collection of new respiratory viral strains circulating in the community will allow hVIVO to continually update and broaden its portfolio of human challenge study models, it explains.

----------

Arc Minerals Ltd - copper and cobalt explorer in Zambia - Updates on the progress of the acquisition of a 74% stake in the Misisi gold project by Rackla Metals Inc, from Golden Square Equity Partners Ltd. Arc sold its interest in Casa Mining Ltd through which it held its interest in Misisi, to Golden Square. Rackla has announced that it continues to work on satisfying the conditions precedent to its proposed acquisition of a 74% interest in Misisi, located in the Democratic Republic of the Congo.

----------

Caracal Gold PLC - gold producer with operations in East Africa - Raises aggregate gross proceeds of GBP2.0 million via a placing of 177 million new shares at a price of 1.12 pence per new share. Shares were acquired by a major shareholder of the company and strategic clients of Clear Capital Markets, the UK-based stockbroker and wealth manager. The placing was extremely well received. Clear Capital Markets will be appointed as joint broker with immediate effect, it adds.

----------

Proton Motor Power Systems PLC - Munich-based producer of hydrogen fuel cells and electric hybrid systems - For 2021, received orders worth EUR3.2 million and, subject to the completion of the audit, the achieved revenue of EUR3.2 million, up from EUR2.1 million in 2020. Says positive trend seen in 2021 has continued into a promising start to 2022. It has already booked orders worth EUR1.3 million from five customers, comprised of repeat orders from two existing customers and three new customer orders. Orders were for the stationary and mobility segments, including large trucks, it notes.

----------

Ethernity Networks Ltd - Israel-based network data processing technology provider - Agrees to restore the plans to produce the contracted UEP platform, which is a higher-end product that better fits the 5G transport market. This includes the original design plan to support 25 GbE, additional L3 features, security functions and power-over-ethernet for radio equipment. Says decision to return to the higher-end version of the UEP, as originally contracted, focuses the market for the products on both distributed-centralized units and wireless bonding, and will result in faster time to revenue for the contracted UEP platform.

----------

Gensource Potash Corp - fertilizer development company located in Saskatchewan, Canada - Says it has reached a confidential settlement agreement with Frank Eberhardt, Carl F Peters GmbH & Co and 11664735 Canada Ltd resolving all legal matters. Gensource says while details of the agreement are confidential, management is pleased with the terms.

----------

CentralNic Group PLC - London-based domain name registry and registrar services firm - Says the strong growth experienced during 2021 has continued into 2022. The year-on-year revenue growth experienced during first quarter to date, which has been driven largely by the performance of the Online Marketing segment, is ahead of the revenue growth rates in analyst consensus expectations for 2022. CentralNic has also agreed to acquire Fireball Search GmbH for a total consideration of EUR600,00 in cash.

----------

Shanta Gold Ltd - east Africa-focused gold producer, developer and explorer - Reports construction progress at the Singida project in Central Tanzania. Says Singida is progressing on schedule and in line with capital spending expectations. Several major project milestones have now been completed on site with construction now 45% complete and a clear path to realising first production within the next 12 months. Total capital spend at Singida in 2022 is estimated at approximately USD25 million resulting in production early 2023, assuming the current guided production forecast at operating mine New Luika gold mine and an average gold price of USD1,800 per ounce, it adds.

----------

KEFI Gold & Copper PLC - gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Updates on joint-venture Tulu Kapi Gold project. Says Ethiopian Ministry of Mines has allowed until July 8 for full project financing and launch commitments to be achieved. JV has been delayed due to outbreak of civil war in Ethiopia, but KEFI says the war abated at the end of 2021, and the state of emergency is being lifted. It now plans to restart project development activities that were suspended in 2021 as a precautionary measure due to the security situation.

----------

Tekcapital PLC - London-based intellectual property investor focused on universities - Says portfolio company Salarius's MicroSalt subsidiary continues its expansion in the low salt and low sodium markets and is pleased to announce that it has executed its first bulk MicroSalt order through Mexican based distribution partner FXM. "This order is a testament to the timeliness of our products and our ability to customize our production for the Mexican market" says Rick Guiney, MicroSalt's CEO.

----------

Amati AIM VCT PLC - investor in AIM-listed companies - Says it has continued to identify and make new investments having considered the current rate of investment activity. As such, it intends to re-open offer for subscription on Wednesday. Company is seeking to raise up to the GBP25 million available under the over-allotment facility.

----------

Character Group PLC - Surrey, England-based toy, games and gifts manufacturer - Buys back GBP13.5 million, as planned, in tender offer for 2.1 million shares at a price of 630 pence per share.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 May 2019 12:23

Polarean Imaging Confirms USD1 Million Cystic Fibrosis Trial Grant

LONDON (Alliance News) - Polarean Imaging PLC said Tuesday it had its third USD1 million tranche of a study grant confirmed for its late stage trial of xenon medical imaging for children being for

Read more
13 May 2019 10:44

Polarean Imaging Progresses On Clinical Trials, To Add New Trial Site

LONDON (Alliance News) - Polarean Imaging PLC on Monday said that it is progressing on its phase III clinical trials and plans to add an extra site in its lung resection pathway trial to improve a

Read more
29 Apr 2019 11:44

Polarean Imaging Hires Charles Osborne As Chief Financial Officer

LONDON (Alliance News) - Medical imaging firm Polarean Imaging PLC said Monday it has hired Charles Osborne as its new chief financial officer with immediate effect.Osborne is currently the

Read more
29 Apr 2019 09:24

Polarean names Charles Osborne as new CFO

(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.

Read more
1 Apr 2019 16:48

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

Read more
11 Mar 2019 18:11

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

Read more
15 Feb 2019 13:46

Polarean Imaging Wins Polarizer System Order From Canadian University

LONDON (Alliance News) - Medical imaging products manufacturer Polarean Imaging PLC said Friday that it has secured a order for its latest polarizer system from the University of British Columbia

Read more
15 Feb 2019 10:27

Polarean Imaging enters contract with University of British Columbia

(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.

Read more
3 Jan 2019 11:45

Amati AIM VCT Builds Over 8% Holding In Polarean Imaging (ALLISS)

LONDON (Alliance News) - Polarean Imaging PLC on Thursday said Amati AIM VCT PLC now holds 8.5% stake in the noble gas polarizer devices manufacturing company.Prior to a transaction on AIM

Read more
11 Dec 2018 13:41

Tuesday broker round-up

(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.

Read more
6 Nov 2018 13:55

Polarean Installs Polariser At University Of Missouri, Gets New Order

LONDON (Alliance News) - Polarean Imaging PLC on Tuesday said it installed and commissioned the latest model of its Xenon polariser to the department of Radiology at University of Missouri Health

Read more
3 Oct 2018 10:19

Polarean Imaging Delivers Xenon Polariser To University Of Missouri

LONDON (Alliance News) - Medical technology company Polarean Imaging PLC on Wednesday said the latest model of its Xenon polariser has been delivered to the radiology department at University of

Read more
23 Aug 2018 15:44

UPDATE: Polarean Imaging Enrols First Patient In 129-Xenon MRI Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more
23 Aug 2018 14:53

Polarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon

(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate non-inferiority of its drug-device combination using hyperpolarised 129-Xenon (129Xe) gas MRI, against an approved comparator.

Read more
23 Aug 2018 11:18

Polarean Imaging Enrols First Patient In 129-Xenon MRI Phase III Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.